New research reveals that people who come off blockbuster slimming jabs like Wegovy and Mounjaro may regain reduced body mass far faster than those who stop traditional lifestyle regimens.
Research printed in a prominent health publication shows that while overweight individuals can lose substantial amounts of their total mass while undergoing treatment, the mass comes back at an average rate of nearly a kilo each month once they quit.
"Individuals using these treatments should be informed of the danger of fast weight regain when the treatment ends," stated lead investigator Dr. Susan Jebb.
This pace of recovery implies a return to pre-treatment mass within about 18 months.
Analyzing Treatments
The analysis, which examined dozens of studies involving thousands of participants, compared the outcomes of these new drugs with other pills.
Researchers point out that people who lose weight through lifestyle changes alone generally experience a less rapid creep back—around 100 grams monthly—after stopping.
The Reason for the Rapid Rebound
Doctors believe the mechanism of the injections accounts for the amplified weight return.
The injections imitate a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Artificially providing the hormone levels far above than the body's typical production may cause the body to generate a reduced amount of its endogenous hormone, and may also diminish sensitivity to its actions," said Dr. Adam Collins, a nutrition expert.
"Stopping of this hormone supplement leads to appetite is no longer kept in check, making binge eating a significant risk."
A Lifelong Issue?
The NHS advise the injections for people with obesity-related health risks, alongside recommended lifestyle changes.
Professionals say that, considering the high risk of weight regain, the treatment is often ongoing.
This opinion is reinforced by drug manufacturers, who state that the results "underscore the long-term nature of obesity," comparing it to managing diseases like high blood pressure.
User Accounts
People who have stopped the jabs explain a intense return of cravings.
"It felt as if a trigger flipping and you're instantly ravenous," said an individual.
This challenge is compounded if users have not adopted sustainable lifestyle or habit modifications during treatment.
Significant Interest
Survey data suggest that millions of people in the UK have used these injections in the last 12 months, with desire being substantial.
- Adoption is greater among women than men.
- The 40s and 50s demographic shows the highest usage rates.
- Many access the drugs through private healthcare rather than the NHS.
Finally, clinicians emphasize that while these medications are effective agents for shedding pounds, they are not a standalone solution and lasting health benefits hinges on integrated lifestyle support.
